Inventiva S.A. (IVA)
Develops oral drugs to treat fatty liver disease and rare metabolic disorders.
$4.64+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+44.1%
The outlook
IVA is trading near the lower end of its 52-week range, with analyst consensus strongly bullish and an average price target roughly 226% above the current price. The stock shows mixed technical positioning relative to its moving averages, suggesting choppy near-term trading despite broad analyst optimism.
What’s behind the score
Analyst consensusStrong Buy — 1.2 avg of 13 analysts
Price trendMixed vs its moving averages
52-week range34% of the way from its 52-week low to high
Price targetAvg target +226% vs current price
Analyst price target
~12-month · 13 analysts$15.13average target+226.0% vs now
Now $4.64
Low $8.80High $26.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.10B
52-wk high
$7.98
52-wk low
$2.94
50-day avg
$4.29
200-day avg
$5.07
Trailing P/E
—